Subscribe to RSS
DOI: 10.1055/s-0040-1722255
Effectiveness and Adverse Effects of Tranexamic Acid in Bleeding during Adenotonsillectomy: A Randomized, Controlled, Double-blind Clinical Trial
Abstract
Introduction Intra and postoperative bleeding are the most frequent and feared complications in adenotonsillectomy (AT). Tranexamic acid (TXA), which is known for its antifibrinolytic effects, has a proven benefit in reducing bleeding in hemorrhagic trauma and cardiac surgery; however, the effectiveness and timing of its application in AT have not yet been established.
Objectives We aimed to evaluate the efficacy of TXA in controlling bleeding during and after AT and assess its possible adverse effects in children.
Methods The present randomized, controlled, double-blind clinical trial included 63 children aged 2 to 12 years. They were randomly assigned to receive either intravenous TXA (10 mg/kg) or placebo 10 minutes before surgery. The volume of intraoperative bleeding, presence of postoperative bleeding, and adverse effects during and 8 hours after the surgery were assessed.
Results No difference in bleeding volume was noted between the 2 groups (mean, 122.7 ml in the TXA group versus 115.5 ml in the placebo group, p = 0.36). No intraoperative or postoperative adverse effects were noted because of TXA use. Furthermore, no primary or secondary postoperative bleeding was observed in any of the participants.
Conclusion In our pediatric sample, TXA (10 mg/kg) administration before AT was safely used, without any adverse effects. It did not reduce the bleeding volume in children during this type of surgery. Future studies should assess the use of higher doses of TXA and its administration at other time points before or during surgery.
Trial Registration ReBEC
U1111–1259–3915
Publication History
Received: 07 August 2020
Accepted: 16 November 2020
Article published online:
19 February 2021
© 2021. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Schmidt R, Herzog A, Cook S, O'Reilly R, Deutsch E, Reilly J. Complications of tonsillectomy: a comparison of techniques. Arch Otolaryngol Head Neck Surg 2007; 133 (09) 925-928 DOI: 10.1001/archotol.133.9.925.
- 2 Collison PJ, Mettler B. Factors associated with post-tonsillectomy hemorrhage. Ear Nose Throat J 2000; 79 (08) 640-642 , 644, 646 passim
- 3 Kain ZN, Mayes LC, Caldwell-Andrews AA, Karas DE, McClain BC. Preoperative anxiety, postoperative pain, and behavioral recovery in young children undergoing surgery. Pediatrics 2006; 118 (02) 651-658 DOI: 10.1542/peds.2005-2920.
- 4 Witzel MA, Rich RH, Margar-Bacal F, Cox C. Velopharyngeal insufficiency after adenoidectomy: an 8-year review. Int J Pediatr Otorhinolaryngol 1986; 11 (01) 15-20 DOI: 10.1016/s0165-5876(86)80023-4.
- 5 Eid NS, Jones VF. Bacterial tracheitis as a complication of tonsillectomy and adenoidectomy. J Pediatr 1994; 125 (03) 401-402 DOI: 10.1016/s0022-3476(05)83284-6.
- 6 Burton MJ, Isaacson G, Rosenfeld RM. Extracts from The Cochrane Library: Tonsillectomy for chronic/recurrent acute tonsillitis. Otolaryngol Head Neck Surg 2009; 140 (01) 15-18
- 7 Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359 (09) 938-949 DOI: 10.1056/NEJMra0801082.
- 8 Leung LLK. Overview of hemostasis [Internet]. [cited 2019 Sep 20). . Available from: http://www.uptodate.com/home/store.do
- 9 Levy JH, Koster A, Quinones QJ, Milling TJ, Key NS. Antifibrinolytic Therapy and Perioperative Considerations. Anesthesiology 2018; 128 (03) 657-670 DOI: 10.1097/ALN.0000000000001997.
- 10 Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57 (06) 1005-1032 DOI: 10.2165/00003495-199957060-00017.
- 11 Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 2005; 102 (04) 727-732 DOI: 10.1097/00000542-200504000-00006.
- 12 Yaniv E, Shvero J, Hadar T. Hemostatic effect of tranexamic acid in elective nasal surgery. Am J Rhinol 2006; 20 (02) 227-229
- 13 Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti AD. Efficacy of tranexamic acid in reducing blood loss after cesarean section. J Matern Fetal Neonatal Med 2009; 22 (01) 72-75 DOI: 10.1080/14767050802353580.
- 14 Myles PS, Smith JA, Forbes A. et al; ATACAS Investigators of the ANZCA Clinical Trials Network. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. N Engl J Med 2017; 376 (02) 136-148 DOI: 10.1056/NEJMoa1606424.
- 15 Wei M, Jian K, Guo Z. et al. Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass grafting. Scand Cardiovasc J 2006; 40 (02) 105-109 DOI: 10.1080/14017430500519864.
- 16 Binz S, McCollester J, Thomas S. et al. CRASH-2 Study of Tranexamic Acid to Treat Bleeding in Trauma Patients: A Controversy Fueled by Science and Social Media. J Blood Transfus 2015; 2015: 874920 DOI: 10.1155/2015/874920.
- 17 Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054 DOI: 10.1136/bmj.e3054.
- 18 Robb PJ. Tranexamic acid - a useful drug in ENT surgery?. J Laryngol Otol 2014; 128 (07) 574-579 DOI: 10.1017/S0022215114001285.
- 19 Brum MR, Miura MS, Castro SF, Machado GM, Lima LH, Lubianca Neto JF. Tranexamic acid in adenotonsillectomy in children: a double-blind randomized clinical trial. Int J Pediatr Otorhinolaryngol 2012; 76 (10) 1401-1405 DOI: 10.1016/j.ijporl.2012.04.028.
- 20 Soliman R, Alshehri A. Assessment of the effect of tranexamic acid on perioperative bleeding in pediatric patients undergoing tonsillectomy. Egypt J Anaesth 2015; 31: 297-301
- 21 Elzayat SD, Elgebaly AS. The role of tranexamic acid in improving quality of pediatric tonsillectomy: a double-blinded randomized controlled study. Menoufia Med J 2018; 31: 98-101
- 22 Sadler JE, Rodeghiero F. ISTH SSC Subcommittee on von Willebrand Factor. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3 (04) 775-777 DOI: 10.1111/j.1538-7836.2005.01245.x.
- 23 Common Terminology Criteria for Adverse Events [Internet]. v4.0 [cited 2016 Oct 18]. . Available from: https://www.eortc.be/services/doc/ctc/CTCAE_4.03_20100614_QuickReference_5x27.pdf
- 24 Castelli G, Vogt E. Der Erfolg einer antifibrinolytischen Behandlung mit Tranexamsäure zur Reduktion des Blutverlustes während und nach Tonsillektomien. [Result of an antifibrinolytic treatment using tranexamic acid for the reduction of blood-loss during and after tonsillectomy] Schweiz Med Wochenschr 1977; 107 (22) 780-784
- 25 Pearson H. Blood and blood forming tissues. In: Rudolph C, Rudolph A. editors. Rudolph's pediatrics. 21st ed.. New York: McGraw-Hill; 2003: 1521
- 26 Koizumi M, Ishimaru M, Matsui H, Fushimi K, Yamasoba T, Yasunaga H. Tranexamic acid and post-tonsillectomy hemorrhage: propensity score and instrumental variable analyses. Eur Arch Otorhinolaryngol 2019; 276 (01) 249-254 DOI: 10.1007/s00405-018-5192-0.
- 27 Shalom AS. Blood loss in ear nose and throat operations. J Laryngol Otol 1964; 78: 734-756 DOI: 10.1017/S0022215100062691.
- 28 Prasad KC, Prasad SC. Assessment of Operative Blood Loss and the Factors Affecting it in Tonsillectomy and Adenotonsillectomy. Indian J Otolaryngol Head Neck Surg 2011; 63 (04) 343-348 DOI: 10.1007/s12070-011-0268-9.